(ASIX) AdvanSix - Ratings and Ratios
Nylon, Caprolactam, Fertilizers, Acetone, Chemicals
ASIX EPS (Earnings per Share)
ASIX Revenue
Description: ASIX AdvanSix
AdvanSix Inc. is a leading manufacturer and seller of polymer resins, operating both domestically and internationally. The companys product portfolio includes Nylon6, a versatile synthetic material used in the production of fibers, filaments, engineered plastics, and films. Additionally, AdvanSix provides caprolactam, a key component in the manufacture of polymer resins, as well as ammonium sulfate fertilizers and acetone, which are used in various industrial applications.
The companys diverse product offerings also include intermediate chemicals such as phenol, alpha-methylstyrene, and cyclohexanone, among others. These products are sold under various brand names, including Aegis, Sulf-N, and Nadone, and are marketed directly to customers as well as through distributors. With its headquarters in Parsippany, New Jersey, AdvanSix has established itself as a significant player in the commodity chemicals industry.
From a technical analysis perspective, the stock has been trading around its 20-day simple moving average (SMA) of $23.95, with the current price at $23.84. The 50-day SMA is at $22.82, indicating a potential support level, while the 200-day SMA is at $26.83, suggesting a longer-term resistance level. The average true range (ATR) is $0.60, representing a volatility of 2.53%. Given these technical indicators, it is likely that the stock will continue to consolidate around its current price level in the short term.
Fundamentally, AdvanSix has a market capitalization of $665.22 million and a price-to-earnings (P/E) ratio of 7.80, indicating a relatively low valuation compared to its peers. The return on equity (RoE) is 11.02%, suggesting a decent level of profitability. With a forecasted earnings growth and a current P/E ratio, we can anticipate the stock to potentially trade higher in the long term, driven by its fundamental strength. Based on the current technical and fundamental data, a potential forecast for the stock could be a price target of $28-$30 in the next 6-12 months, driven by a combination of its low valuation, decent profitability, and potential for earnings growth.
ASIX Stock Overview
| Market Cap in USD | 576m |
| Sub-Industry | Commodity Chemicals |
| IPO / Inception | 2016-10-03 |
ASIX Stock Ratings
| Growth Rating | -57.0% |
| Fundamental | 45.4% |
| Dividend Rating | 72.5% |
| Return 12m vs S&P 500 | -36.6% |
| Analyst Rating | - |
ASIX Dividends
| Dividend Yield 12m | 2.83% |
| Yield on Cost 5y | 5.64% |
| Annual Growth 5y | 50.42% |
| Payout Consistency | 100.0% |
| Payout Ratio | 20.9% |
ASIX Growth Ratios
| Growth Correlation 3m | -63.8% |
| Growth Correlation 12m | -80% |
| Growth Correlation 5y | -25% |
| CAGR 5y | -12.83% |
| CAGR/Max DD 3y | -0.23 |
| CAGR/Mean DD 3y | -0.40 |
| Sharpe Ratio 12m | -2.29 |
| Alpha | 0.16 |
| Beta | 0.000 |
| Volatility | 36.34% |
| Current Volume | 201.1k |
| Average Volume 20d | 201.1k |
| Stop Loss | 20 (-4.4%) |
| Signal | 0.08 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (77.3m TTM) > 0 and > 6% of Revenue (6% = 90.9m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 2.66pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.47% (prev 7.06%; Δ 0.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 154.0m > Net Income 77.3m (YES >=105%, WARN >=100%) |
| Net Debt (359.3m) to EBITDA (79.5m) ratio: 4.52 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (27.2m) change vs 12m ago 0.36% (target <= -2.0% for YES) |
| Gross Margin 11.93% (prev 7.42%; Δ 4.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 96.98% (prev 101.2%; Δ -4.20pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.33 (EBITDA TTM 79.5m / Interest Expense TTM 8.89m) >= 6 (WARN >= 3) |
Altman Z'' 2.68
| (A) 0.07 = (Total Current Assets 434.2m - Total Current Liabilities 321.1m) / Total Assets 1.65b |
| (B) 0.41 = Retained Earnings (Balance) 677.4m / Total Assets 1.65b |
| (C) 0.00 = EBIT TTM 2.96m / Avg Total Assets 1.56b |
| (D) 0.83 = Book Value of Equity 683.7m / Total Liabilities 822.7m |
| Total Rating: 2.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 45.41
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield 6.58% = 3.29 |
| 3. FCF Margin 3.63% = 0.91 |
| 4. Debt/Equity 0.34 = 2.44 |
| 5. Debt/Ebitda 3.51 = -2.31 |
| 6. ROIC - WACC (= -4.03)% = -5.03 |
| 7. RoE 9.79% = 0.82 |
| 8. Rev. Trend -32.40% = -2.43 |
| 9. EPS Trend 4.54% = 0.23 |
What is the price of ASIX shares?
Over the past week, the price has changed by +1.31%, over one month by +4.24%, over three months by -11.44% and over the past year by -24.83%.
Is AdvanSix a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ASIX is around 19.11 USD . This means that ASIX is currently overvalued and has a potential downside of -8.61%.
Is ASIX a buy, sell or hold?
What are the forecasts/targets for the ASIX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28 | 33.9% |
| Analysts Target Price | 28 | 33.9% |
| ValueRay Target Price | 20.5 | -1.9% |
Last update: 2025-09-15 04:31
ASIX Fundamental Data Overview
CCE Cash And Equivalents = 18.4m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 7.5599
P/S = 0.3804
P/B = 0.6997
Beta = 1.638
Revenue TTM = 1.52b USD
EBIT TTM = 2.96m USD
EBITDA TTM = 79.5m USD
Long Term Debt = 240.0m USD (from longTermDebt, last quarter)
Short Term Debt = 38.7m USD (from shortTermDebt, last quarter)
Debt = 278.7m USD (Calculated: Short Term 38.7m + Long Term 240.0m)
Net Debt = 359.3m USD (from netDebt column, last quarter)
Enterprise Value = 836.6m USD (576.3m + Debt 278.7m - CCE 18.4m)
Interest Coverage Ratio = 0.33 (Ebit TTM 2.96m / Interest Expense TTM 8.89m)
FCF Yield = 6.58% (FCF TTM 55.1m / Enterprise Value 836.6m)
FCF Margin = 3.63% (FCF TTM 55.1m / Revenue TTM 1.52b)
Net Margin = 5.10% (Net Income TTM 77.3m / Revenue TTM 1.52b)
Gross Margin = 11.93% ((Revenue TTM 1.52b - Cost of Revenue TTM 1.33b) / Revenue TTM)
Tobins Q-Ratio = 1.22 (Enterprise Value 836.6m / Book Value Of Equity 683.7m)
Interest Expense / Debt = 0.81% (Interest Expense 2.25m / Debt 278.7m)
Taxrate = 3.13% (1.43m / 45.6m)
NOPAT = 2.87m (EBIT 2.96m * (1 - 3.13%))
Current Ratio = 1.35 (Total Current Assets 434.2m / Total Current Liabilities 321.1m)
Debt / Equity = 0.34 (Debt 278.7m / last Quarter total Stockholder Equity 823.7m)
Debt / EBITDA = 3.51 (Net Debt 359.3m / EBITDA 79.5m)
Debt / FCF = 5.06 (Debt 278.7m / FCF TTM 55.1m)
Total Stockholder Equity = 789.8m (last 4 quarters mean)
RoA = 4.70% (Net Income 77.3m, Total Assets 1.65b )
RoE = 9.79% (Net Income TTM 77.3m / Total Stockholder Equity 789.8m)
RoCE = 0.29% (Ebit 2.96m / (Equity 789.8m + L.T.Debt 240.0m))
RoIC = 0.29% (NOPAT 2.87m / Invested Capital 1.01b)
WACC = 4.31% (E(576.3m)/V(855.1m) * Re(6.02%)) + (D(278.7m)/V(855.1m) * Rd(0.81%) * (1-Tc(0.03)))
Shares Correlation 3-Years: -33.33 | Cagr: -0.53%
Discount Rate = 6.02% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈37.1m ; Y1≈24.4m ; Y5≈11.1m
Fair Price DCF = 8.16 (DCF Value 219.0m / Shares Outstanding 26.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 4.54 | EPS CAGR: 58.40% | SUE: 0.22 | # QB: 0
Revenue Correlation: -32.40 | Revenue CAGR: -5.48% | SUE: 4.0 | # QB: 2
Additional Sources for ASIX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle